Waters Corporation WAT

433.54 3.24 0.75% as of 25 Sep
Market cap
$42.3B
P/E
108×
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month

Waters Corporation (WAT) P/B ratio

As of 25 September 2026, Waters Corporation (WAT) trades at a P/B ratio of 2.8×. Over the past ten years it has ranged from 0.0× (December 2020) to 134× (December 2019); the current reading is higher than 13% of that period. That is below the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 8.8× (26.71%)
FY2024 12.0× (28.67%)
FY2023 16.9× (58.93%)
FY2022 41.1× (34.17%)
FY2021 62.4× (5.68%)
FY2020 66.2× —
FY2019 0.0× —
FY2018 9.3× 32.58%
FY2017 7.0× 45.99%
FY2016 4.8× (11.04%)

Quarterly

Period P/B ratio Change
Jun 2026 2.4× 51.53%
Mar 2026 1.6× (81.87%)
Dec 2025 8.8× 15.22%
Sep 2025 7.7× (20.38%)
42 more quarters

Against its own ten years

Low 0.0× High 134×
Ten-year median 8.4×
Current reading's percentile 13

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
WAT Waters Corporation 2.8×
DGX Quest Diagnostics Incorporated compare 3.4×
A Agilent Technologies, Inc. compare 6.6×
IQV IQVIA Holdings Inc. compare 7.1×
ILMN Illumina, Inc. compare 14.5×
IDXX IDEXX Laboratories, Inc. compare 25.4×
NTRA Natera, Inc. compare 32.5×
MTD Mettler-Toledo International, Inc. compare 2,372×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on WAT